Novo Nordisk claims obesity drug effective for under-12s - Financial Times
- Novo Nordisk claims obesity drug effective for under-12s Financial Times
- Weight-loss drug Saxenda effective for kids as young as 6, study shows The Associated Press
- Weight loss drug liraglutide shows promise for younger children with obesity, study finds CNN
- Obesity drug worked in children ages 6 to 12, study says, raising hopes and concerns STAT